Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Abbott Laboratories Banner

Abbott Laboratories

ABT Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
2.284B1.583B1.375B477.000M2.368B3.687B4.495B7.071B6.933B5.701B
Depreciation & Amortization
1.548B1.472B1.353B3.021B3.278B3.014B3.327B3.538B3.267B3.243B
Change in Working Capital
-490.000m-156.000m-1.513b1.915B-148.000m-1.331b-892.000m-771.000m-1.519b-2.475b
Operating Cash Flow
3.675B2.966B3.203B5.570B6.300B6.136B7.901B10.533B9.581B7.261B
Capital Expenditure
-1.077b-1.110b-1.121b-1.135b-1.394b-1.638b-2.177b-1.885b-1.777b-2.202b
Free Cash Flow
2.598B1.856B2.082B4.435B4.906B4.498B5.724B8.648B7.804B5.059B
Debt Repayment
-577.000m-57.000m-12.000m-8.650b-12.433b-3.441b-1.333b-48.000m-753.000m-2.475b
Dividends Paid
-1.342b-1.443b-1.539b-1.849b-1.974b-2.270b-2.560b-3.202b-3.309b-3.556b
Common Stock Issued
1.772B1.518B13.415B6.058B271.000M298.000M1.528B255.000M167.000M167.000M
Common Stock Repurchased
-2.195b-2.237b-522.000m-827.000m-238.000m-718.000m-403.000m-2.299b-3.795b-1.227b
Net Change in Cash
588.000M938.000M13.619B-9.213b-5.563b16.000M2.978B2.961B83.000M-2.986b